Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

374 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-d]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against Glioblastoma Multiforme.
Poggialini F, Vagaggini C, Brai A, Pasqualini C, Crespan E, Maga G, Perini C, Cabella N, Botta L, Musumeci F, Frosini M, Schenone S, Dreassi E. Poggialini F, et al. Among authors: musumeci f. Pharmaceutics. 2023 Jan 30;15(2):453. doi: 10.3390/pharmaceutics15020453. Pharmaceutics. 2023. PMID: 36839775 Free PMC article.
Design, synthesis, biological activity, and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization study.
Radi M, Dreassi E, Brullo C, Crespan E, Tintori C, Bernardo V, Valoti M, Zamperini C, Daigl H, Musumeci F, Carraro F, Naldini A, Filippi I, Maga G, Schenone S, Botta M. Radi M, et al. Among authors: musumeci f. J Med Chem. 2011 Apr 28;54(8):2610-26. doi: 10.1021/jm1012819. Epub 2011 Mar 28. J Med Chem. 2011. PMID: 21443205
An update on dual Src/Abl inhibitors.
Musumeci F, Schenone S, Brullo C, Botta M. Musumeci F, et al. Future Med Chem. 2012 Apr;4(6):799-822. doi: 10.4155/fmc.12.29. Future Med Chem. 2012. PMID: 22530642 Review.
A combined targeted/phenotypic approach for the identification of new antiangiogenics agents active on a zebrafish model: from in silico screening to cyclodextrin formulation.
Radi M, Evensen L, Dreassi E, Zamperini C, Caporicci M, Falchi F, Musumeci F, Schenone S, Lorens JB, Botta M. Radi M, et al. Among authors: musumeci f. Bioorg Med Chem Lett. 2012 Sep 1;22(17):5579-83. doi: 10.1016/j.bmcl.2012.07.014. Epub 2012 Jul 13. Bioorg Med Chem Lett. 2012. PMID: 22853993
374 results